NASA Astrophysics Advisory Committee; Meeting, 10358-10359 [2021-03372]

Download as PDF 10358 Federal Register / Vol. 86, No. 32 / Friday, February 19, 2021 / Notices Controlled substance Drug code tkelley on DSKBCP9HB2PROD with NOTICES JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ...................................................................................................... UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .................................................................. JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ...................................................................................................... Ibogaine ........................................................................................................................................................................... Lysergic acid diethylamide .............................................................................................................................................. Marihuana Extract ........................................................................................................................................................... Marihuana ........................................................................................................................................................................ Tetrahydrocannabinols .................................................................................................................................................... Mescaline ......................................................................................................................................................................... JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ...................................................................................................... 3,4-Methylenedioxymethamphetamine ............................................................................................................................ 5-Methoxy-N–N-dimethyltryptamine ................................................................................................................................ Psilocyn ........................................................................................................................................................................... 4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) ..................................................................................................... MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... Methylone (3,4-Methylenedioxy-N-methylcathinone) ...................................................................................................... Butylone ........................................................................................................................................................................... Pentylone ......................................................................................................................................................................... Codeine-N-oxide .............................................................................................................................................................. Desomorphine ................................................................................................................................................................. Dihydromorphine ............................................................................................................................................................. Heroin .............................................................................................................................................................................. Morphine-N-oxide ............................................................................................................................................................ Normorphine .................................................................................................................................................................... Tilidine ............................................................................................................................................................................. Alpha-methylfentanyl ....................................................................................................................................................... Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ............................................................................... Methamphetamine ........................................................................................................................................................... Phenmetrazine ................................................................................................................................................................. Methylphenidate .............................................................................................................................................................. Amobarbital ...................................................................................................................................................................... Pentobarbital .................................................................................................................................................................... Secobarbital ..................................................................................................................................................................... Glutethimide ..................................................................................................................................................................... Phencyclidine ................................................................................................................................................................... 4-Anilino-N-phenethyl-4-piperidine (ANPP) ..................................................................................................................... Norfentanyl ...................................................................................................................................................................... Phenylacetone ................................................................................................................................................................. Codeine ........................................................................................................................................................................... Dihydrocodeine ................................................................................................................................................................ Diphenoxylate .................................................................................................................................................................. Ecgonine .......................................................................................................................................................................... Ethylmorphine .................................................................................................................................................................. Hydrocodone ................................................................................................................................................................... Levorphanol ..................................................................................................................................................................... Meperidine ....................................................................................................................................................................... Meperidine intermediate-B .............................................................................................................................................. Meperidine intermediate-C .............................................................................................................................................. Methadone intermediate .................................................................................................................................................. Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. Morphine .......................................................................................................................................................................... Thebaine .......................................................................................................................................................................... 14-Hydroxmorphone ........................................................................................................................................................ Noroxymorphone ............................................................................................................................................................. Sufentanil ......................................................................................................................................................................... Fentanyl ........................................................................................................................................................................... The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis. In reference to drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols) the company plans to import a synthetic cannabidiol and a synthetic tetrahydrocannabinol. No other activities for these drug codes are authorized for this registration. Approval of permit applications will occur only when the registrant’s VerDate Sep<11>2014 21:07 Feb 18, 2021 Jkt 253001 business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. William T. McDermott, Assistant Administrator. [FR Doc. 2021–03381 Filed 2–18–21; 8:45 am] BILLING CODE 4410–09–P PO 00000 Frm 00126 Fmt 4703 Sfmt 4703 7118 7122 7144 7203 7260 7315 7350 7360 7370 7381 7398 7405 7431 7438 7498 7535 7540 7541 7542 9053 9055 9145 9200 9307 9313 9750 9814 9821 1105 1631 1724 2125 2270 2315 2550 7471 8333 8366 8501 9050 9120 9170 9180 9190 9193 9220 9230 9233 9234 9254 9273 9300 9333 9665 9668 9740 9801 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I II II II II II II II II II II II II II II II II II II II II II II II II II II II II II NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice: (21–009)] NASA Astrophysics Advisory Committee; Meeting National Aeronautics and Space Administration. ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, Public SUMMARY: E:\FR\FM\19FEN1.SGM 19FEN1 tkelley on DSKBCP9HB2PROD with NOTICES Federal Register / Vol. 86, No. 32 / Friday, February 19, 2021 / Notices Law 92–463, as amended, the National Aeronautics and Space Administration (NASA) announces a meeting of the Astrophysics Advisory Committee. This Committee reports to the Director, Astrophysics Division, Science Mission Directorate, NASA Headquarters. The meeting will be held for the purpose of soliciting, from the scientific community and other persons, scientific and technical information relevant to program planning. DATES: Monday, March 15, 2021, 11:00 a.m.–5:00 p.m.; Tuesday, March 16, 2021, 11:00 a.m.–5:00 p.m.; and Wednesday, March 17, 2021, 11:00 a.m.–5:00 p.m.; Eastern Time. FOR FURTHER INFORMATION CONTACT: Ms. KarShelia Henderson, Science Mission Directorate, NASA Headquarters, Washington, DC 20546, (202) 358–2355, or khenderson@nasa.gov. SUPPLEMENTARY INFORMATION: The meeting will be available to the public by WebEx. On Monday, March 15, the event address for attendees is: https:// nasaenterprise.webex.com/ nasaenterprise/j.php?MTID=md56c2364 ad7f625bf9121430ef9d85f9, the meeting number is 199 340 9228, and meeting password is MJh8JVDV89@. On Tuesday, March 16, the event address for attendees is: https:// nasaenterprise.webex.com/ nasaenterprise/j.php?MTID= m1ce0a71960e457179b7e 85dcc41de62b, the meeting number is 199 888 1998, and meeting password is csAvpYM2@78. On Wednesday, March 17, the event address for attendees is: https:// nasaenterprise.webex.com/ nasaenterprise/j.php?MTID= m26744d6e150f086b3cf3ed99bd6649fa, the meeting number is 199 029 2743, and meeting password is 9skWYje8P@3. To join by telephone, the numbers are: 1–929–251–9612 or 1–415–527– 5035, for each day. The agenda for the meeting includes the following topics: —Astrophysics Division Update —Updates on Specific Astrophysics Missions —Reports from the Program Analysis Groups —Reports from Specific Research and Analysis Programs The agenda will be posted on the Astrophysics Advisory Committee web page: https://science.nasa.gov/ researchers/nac/science-advisorycommittees/apac. The public may submit and upvote comments/questions ahead of the meeting through the website https:// arc.cnf.io/sessions/mkky/#!/dashboard VerDate Sep<11>2014 21:07 Feb 18, 2021 Jkt 253001 10359 that will be opened for input on March 1, 2021. It is imperative that the meeting be held on this date to accommodate the scheduling priorities of the key participants. Dated: February 16, 2021. Crystal Robinson, Committee Management Officer. Patricia Rausch, Advisory Committee Management Officer, National Aeronautics and Space Administration. NATIONAL SCIENCE FOUNDATION [FR Doc. 2021–03372 Filed 2–18–21; 8:45 am] BILLING CODE 7510–13–P [FR Doc. 2021–03389 Filed 2–18–21; 8:45 am] BILLING CODE 7555–01–P Sunshine Act Meetings The National Science Board (NSB) hereby gives notice of the scheduling of meetings for the transaction of NSB business as follows: Tuesday, February 23, 2021, from 11:00 a.m. to 6:45 p.m., and Wednesday, February 24, 2021, from 11:00 a.m. to 6:40 p.m. EST. PLACE: These meetings will be held by videoconference. There will be no inperson meetings. The public may observe the public meetings, which will be streamed to the NSF You Tube channel. For meetings on Tuesday, February 23, go to: https://youtu.be/ 6JjWhwMhIKM. For meetings on Wednesday, February 24, go to: https:// youtu.be/tmiQwe7o_Y0. STATUS: Parts of these meetings will be open to the public. The rest of the meetings will be closed to the public. See full description below. MATTERS TO BE CONSIDERED: TIME AND DATE: NATIONAL SCIENCE FOUNDATION Advisory Committee for International Science and Engineering; Notice of Meeting In accordance with the Federal Advisory Committee Act (Pub. L. 92–463, as amended), the National Science Foundation (NSF) announces the following meeting: Name and Committee Code: Advisory Committee for International Science and Engineering Meeting (AC–ISE) (#25104). Date and Time: Friday, March 19, 2021, 10:00 a.m. to 5:00 p.m. (Eastern Time). Place: NSF, 2415 Eisenhower Avenue, Alexandria, VA 22314 | Virtual Zoom. This AC–ISE meeting is fully virtual. All public participants are required to process the meeting registration via Zoom. Connect to The Virtual Meeting: Register in advance for the meeting at the Zoom attendee registration link: https://nsf.zoomgov.com/webinar/ register/WN_ IRrGAhXcRO2DvpdH7jAVjA. After registering, you will receive a confirmation email with a unique link to join the meeting. If you have any login questions, please contact Kirk Grabowski, OISE IT Specialist: kgrabows@associates.nsf.gov. Type of Meeting: Open. Contact Person: Christopher Street, National Science Foundation, 2415 Eisenhower Avenue, Room W–17220, Alexandria, Virginia 22314; Telephone: (703) 292–8568/Email: cstreet@nsf.gov. Purpose of Meeting: To provide advice, recommendations and counsel on major goals and policies pertaining to international programs and activities. Agenda • Updates on OISE activities • Discussion on Global Leadership in Science, Engineering, and Education • Innovative Partnerships • Meet with NSF leadership PO 00000 Frm 00127 Fmt 4703 Sfmt 4703 Tuesday, February 23, 2021 Plenary Board Meeting Open Session: 11:00 a.m.–1:05 p.m. • NSB Chair’s Remarks • New Member Swearing-in Matthew Malkan Scott Stanley • NSF Director’s Remarks • NSB Chair Activity Summary • Racial Equity Task Force and NSF Harassment Policy Update • Vision 2030 Implementation Working Group Update Committee on Oversight (CO) Open Session: 1:15 p.m.–2:25 p.m. • Committee Chair’s Opening Remarks • Approval of Committee Meeting Minutes • Broader Impacts—Update on Activities Discussion and action on statement and resolution re: Reviewer Training Discussion and action on statement and resolution re: Broader Impacts Expert on Committees of Visitors • Inspector General’s Update • Chief Financial Officer’s Update Committee on National Science and Engineering Policy (SEP) Open Session: 2:35 p.m.–3:25 p.m. • Committee Chair’s Opening Remarks E:\FR\FM\19FEN1.SGM 19FEN1

Agencies

[Federal Register Volume 86, Number 32 (Friday, February 19, 2021)]
[Notices]
[Pages 10358-10359]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03372]


=======================================================================
-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice: (21-009)]


NASA Astrophysics Advisory Committee; Meeting

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, Public

[[Page 10359]]

Law 92-463, as amended, the National Aeronautics and Space 
Administration (NASA) announces a meeting of the Astrophysics Advisory 
Committee. This Committee reports to the Director, Astrophysics 
Division, Science Mission Directorate, NASA Headquarters. The meeting 
will be held for the purpose of soliciting, from the scientific 
community and other persons, scientific and technical information 
relevant to program planning.

DATES: Monday, March 15, 2021, 11:00 a.m.-5:00 p.m.; Tuesday, March 16, 
2021, 11:00 a.m.-5:00 p.m.; and Wednesday, March 17, 2021, 11:00 a.m.-
5:00 p.m.; Eastern Time.

FOR FURTHER INFORMATION CONTACT: Ms. KarShelia Henderson, Science 
Mission Directorate, NASA Headquarters, Washington, DC 20546, (202) 
358-2355, or [email protected].

SUPPLEMENTARY INFORMATION: The meeting will be available to the public 
by WebEx.
    On Monday, March 15, the event address for attendees is: https://nasaenterprise.webex.com/nasaenterprise/j.php?MTID=md56c2364ad7f625bf9121430ef9d85f9, the meeting number is 199 
340 9228, and meeting password is [email protected]
    On Tuesday, March 16, the event address for attendees is: https://nasaenterprise.webex.com/nasaenterprise/j.php?MTID=m1ce0a71960e457179b7e85dcc41de62b, the meeting number is 199 
888 1998, and meeting password is [email protected]
    On Wednesday, March 17, the event address for attendees is: https://nasaenterprise.webex.com/nasaenterprise/j.php?MTID=m26744d6e150f086b3cf3ed99bd6649fa, the meeting number is 199 
029 2743, and meeting password is [email protected]
    To join by telephone, the numbers are: 1-929-251-9612 or 1-415-527-
5035, for each day.
    The agenda for the meeting includes the following topics:

--Astrophysics Division Update
--Updates on Specific Astrophysics Missions
--Reports from the Program Analysis Groups
--Reports from Specific Research and Analysis Programs

    The agenda will be posted on the Astrophysics Advisory Committee 
web page: https://science.nasa.gov/researchers/nac/science-advisory-committees/apac.
    The public may submit and upvote comments/questions ahead of the 
meeting through the website https://arc.cnf.io/sessions/mkky/#!/dashboard that will be opened for input on March 1, 2021.
    It is imperative that the meeting be held on this date to 
accommodate the scheduling priorities of the key participants.

Patricia Rausch,
Advisory Committee Management Officer, National Aeronautics and Space 
Administration.
[FR Doc. 2021-03372 Filed 2-18-21; 8:45 am]
BILLING CODE 7510-13-P